These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 32320387)
1. Drugs for Depression. Med Lett Drugs Ther; 2020 Feb; 62(1592):25-32. PubMed ID: 32320387 [No Abstract] [Full Text] [Related]
2. Drugs for depressionr. Med Lett Drugs Ther; 2023 Dec; 65(1691):193-200. PubMed ID: 38133585 [No Abstract] [Full Text] [Related]
3. Drugs for anxiety disorders. Med Lett Drugs Ther; 2023 Aug; 65(1682):121-128. PubMed ID: 37516898 [No Abstract] [Full Text] [Related]
4. Drugs for anxiety disorders. Med Lett Drugs Ther; 2019 Aug; 61(1578):121-126. PubMed ID: 31386647 [No Abstract] [Full Text] [Related]
5. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442 [TBL] [Abstract][Full Text] [Related]
6. Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis. Tran BX; Ha GH; Vu GT; Nguyen LH; Latkin CA; Nathan K; McIntyre RS; Ho CS; Tam WW; Ho RC Int J Environ Res Public Health; 2019 Jun; 16(13):. PubMed ID: 31247926 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis. Rao Y; Yang R; Zhao J; Cao Q Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 51(4):480-490. PubMed ID: 37202104 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172 [TBL] [Abstract][Full Text] [Related]
10. Beneficial and harmful effects of antidepressants versus placebo, 'active placebo', or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses. Juul S; Siddiqui F; Barbateskovic M; Jørgensen CK; Hengartner MP; Kirsch I; Gluud C; Jakobsen JC Syst Rev; 2021 May; 10(1):154. PubMed ID: 34034811 [TBL] [Abstract][Full Text] [Related]
11. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Hayasaka Y; Purgato M; Magni LR; Ogawa Y; Takeshima N; Cipriani A; Barbui C; Leucht S; Furukawa TA J Affect Disord; 2015 Jul; 180():179-84. PubMed ID: 25911132 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Antidepressants in Combination with Psychotherapy. Alemi F; Soylu TG; Cannon M; McCandless C J Ment Health Policy Econ; 2024 Mar; 27(1):3-12. PubMed ID: 38634393 [TBL] [Abstract][Full Text] [Related]
13. Cariprazine (Vraylar) for adjunctive treatment of depression. Med Lett Drugs Ther; 2023 May; 65(1677):84-86. PubMed ID: 37216200 [No Abstract] [Full Text] [Related]
14. Drugs for bipolar disorder. Med Lett Drugs Ther; 2024 Apr; 66(1699):49-54. PubMed ID: 38576143 [No Abstract] [Full Text] [Related]
15. Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies. Mika J; Zychowska M; Makuch W; Rojewska E; Przewlocka B Pharmacol Rep; 2013; 65(6):1611-21. PubMed ID: 24553009 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis. Furukawa TA; Salanti G; Atkinson LZ; Leucht S; Ruhe HG; Turner EH; Chaimani A; Ogawa Y; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Suganuma A; Watanabe N; Stockton S; Geddes JR; Cipriani A BMJ Open; 2016 Jul; 6(7):e010919. PubMed ID: 27401359 [TBL] [Abstract][Full Text] [Related]
17. Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis. Tomlinson A; Efthimiou O; Boaden K; New E; Mather S; Salanti G; Imai H; Ogawa Y; Tajika A; Kishimoto S; Kikuchi S; Chevance A; Furukawa TA; Cipriani A Evid Based Ment Health; 2019 May; 22(2):61-66. PubMed ID: 30996028 [TBL] [Abstract][Full Text] [Related]
18. Brexpiprazole (Rexulti) for agitation in Alzheimer's dementia. Med Lett Drugs Ther; 2023 Jun; 65(1679):99-101. PubMed ID: 37339089 [No Abstract] [Full Text] [Related]
19. Comparative efficacy and acceptability of antidepressants in the long-term treatment of major depression: protocol for a systematic review and networkmeta-analysis. Shinohara K; Efthimiou O; Ostinelli EG; Tomlinson A; Geddes JR; Nierenberg AA; Ruhe HG; Furukawa TA; Cipriani A BMJ Open; 2019 May; 9(5):e027574. PubMed ID: 31110100 [TBL] [Abstract][Full Text] [Related]